Back to Trades
Boucher Kelley
InsiderCIK 0002070437
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Boucher Kelley has filed 2 SEC reports (2025–2026), all concentrated in Apellis Pharmaceuticals, Inc. (APLS), totaling $4.4M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Boucher Kelley | Insider | Grant | $3.2M |
| Sep 3 | APLS Apellis Pharmaceuticals, Inc. | Boucher Kelley | Chief People Officer | Grant | $1.3M |
2 filings